257 related articles for article (PubMed ID: 26379360)
21. Long noncoding RNAs as potential biomarkers in gastric cancer: Opportunities and challenges.
Yang Z; Guo X; Li G; Shi Y; Li L
Cancer Lett; 2016 Feb; 371(1):62-70. PubMed ID: 26577810
[TBL] [Abstract][Full Text] [Related]
22. Cancer risk to the gastric corpus in Japanese, its correlation with interleukin-1beta gene polymorphism (+3953*T) and Epstein-Barr virus infection.
Sakuma K; Uozaki H; Chong JM; Hironaka M; Sudo M; Ushiku T; Nagai H; Fukayama M
Int J Cancer; 2005 May; 115(1):93-7. PubMed ID: 15688413
[TBL] [Abstract][Full Text] [Related]
23. Pathogenesis of Gastric Cancer.
Figueiredo C; Costa S; Karameris A; Machado JC
Helicobacter; 2015 Sep; 20 Suppl 1():30-5. PubMed ID: 26372822
[TBL] [Abstract][Full Text] [Related]
24. Role of non-coding RNA in immune microenvironment and anticancer therapy of gastric cancer.
Chen L; Deng J
J Mol Med (Berl); 2022 Dec; 100(12):1703-1719. PubMed ID: 36329206
[TBL] [Abstract][Full Text] [Related]
25. Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis.
Cheng AS; Li MS; Kang W; Cheng VY; Chou JL; Lau SS; Go MY; Lee CC; Ling TK; Ng EK; Yu J; Huang TH; To KF; Chan MW; Sung JJ; Chan FK
Gastroenterology; 2013 Jan; 144(1):122-133.e9. PubMed ID: 23058321
[TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor beta 1 (TGF-β1) modulates Epstein-Barr virus reactivation in absence of Helicobacter pylori infection in patients with gastric cancer.
Shukla SK; Khatoon J; Prasad KN; Rai RP; Singh AK; Kumar S; Ghoshal UC; Krishnani N
Cytokine; 2016 Jan; 77():176-9. PubMed ID: 26239415
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of long noncoding RNA ZMAT1 transcript variant 2 predicts a poor prognosis in patients with gastric cancer.
Lai Y; Xu P; Li Q; Ren D; Wang J; Xu K; Gao W
Int J Clin Exp Pathol; 2015; 8(5):5556-62. PubMed ID: 26191264
[TBL] [Abstract][Full Text] [Related]
28. Chromatin and noncoding RNA-mediated mechanisms of gastric tumorigenesis.
Loe AKH; Zhu L; Kim TH
Exp Mol Med; 2023 Jan; 55(1):22-31. PubMed ID: 36653445
[TBL] [Abstract][Full Text] [Related]
29. Genetic variations in miR-27a gene decrease mature miR-27a level and reduce gastric cancer susceptibility.
Yang Q; Jie Z; Ye S; Li Z; Han Z; Wu J; Yang C; Jiang Y
Oncogene; 2014 Jan; 33(2):193-202. PubMed ID: 23246964
[TBL] [Abstract][Full Text] [Related]
30. LncRNAs: emerging biomarkers in gastric cancer.
Gu Y; Chen T; Li G; Yu X; Lu Y; Wang H; Teng L
Future Oncol; 2015; 11(17):2427-41. PubMed ID: 26289363
[TBL] [Abstract][Full Text] [Related]
31. Noncoding RNAs and pancreatic cancer.
Peng JF; Zhuang YY; Huang FT; Zhang SN
World J Gastroenterol; 2016 Jan; 22(2):801-14. PubMed ID: 26811626
[TBL] [Abstract][Full Text] [Related]
32. Association of gastric cancer risk factors with DNA methylation levels in gastric mucosa of healthy Japanese: a cross-sectional study.
Shimazu T; Asada K; Charvat H; Kusano C; Otake Y; Kakugawa Y; Watanabe H; Gotoda T; Ushijima T; Tsugane S
Carcinogenesis; 2015 Nov; 36(11):1291-8. PubMed ID: 26354778
[TBL] [Abstract][Full Text] [Related]
33. Changes in aberrant DNA methylation after Helicobacter pylori eradication: a long-term follow-up study.
Shin CM; Kim N; Lee HS; Park JH; Ahn S; Kang GH; Kim JM; Kim JS; Lee DH; Jung HC
Int J Cancer; 2013 Nov; 133(9):2034-42. PubMed ID: 23595635
[TBL] [Abstract][Full Text] [Related]
34. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.
Liang Q; Yao X; Tang S; Zhang J; Yau TO; Li X; Tang CM; Kang W; Lung RW; Li JW; Chan TF; Xing R; Lu Y; Lo KW; Wong N; To KF; Yu C; Chan FK; Sung JJ; Yu J
Gastroenterology; 2014 Dec; 147(6):1350-62.e4. PubMed ID: 25173755
[TBL] [Abstract][Full Text] [Related]
35. Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression.
Lu XX; Yu JL; Ying LS; Han J; Wang S; Yu QM; Wang XB; Fang XH; Ling ZQ
Cancer; 2012 Nov; 118(22):5507-17. PubMed ID: 22576578
[TBL] [Abstract][Full Text] [Related]
36. Dysregulation of non-coding RNAs in gastric cancer.
Yang Q; Zhang RW; Sui PC; He HT; Ding L
World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
[TBL] [Abstract][Full Text] [Related]
37. [SIGNIFICANCE OF NONCODING RNAS IN COLORECTAL CANCER: REVIEW].
Toiyama Y; Kusunoki M
Nihon Geka Gakkai Zasshi; 2015 Nov; 116(6):360-5. PubMed ID: 26845887
[TBL] [Abstract][Full Text] [Related]
38. Novel biomarkers for the identification and targeted therapy of gastric cancer.
Liu L; Cao L; Gong B; Yu J
Expert Rev Gastroenterol Hepatol; 2015; 9(9):1217-26. PubMed ID: 26220043
[TBL] [Abstract][Full Text] [Related]
39. Genetics/genomics/proteomics of gastric adenocarcinoma.
Uppal DS; Powell SM
Gastroenterol Clin North Am; 2013 Jun; 42(2):241-60. PubMed ID: 23639639
[TBL] [Abstract][Full Text] [Related]
40. Detection and Clinical Significance of COX-2 Gene SNPs in Gastric Cancer.
Lu X; Chen F; Liu X; Yuan D; Zi Y; He X; He R
Cell Biochem Biophys; 2015 Jul; 72(3):657-60. PubMed ID: 27352184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
